OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Smoothened Promotes Glioblastoma Radiation Resistance Via Activating USP3-Mediated Claspin Deubiquitination
Yiming Tu, Zhenyao Chen, Pengzhan Zhao, et al.
Clinical Cancer Research (2020) Vol. 26, Iss. 7, pp. 1749-1762
Open Access | Times Cited: 45
Yiming Tu, Zhenyao Chen, Pengzhan Zhao, et al.
Clinical Cancer Research (2020) Vol. 26, Iss. 7, pp. 1749-1762
Open Access | Times Cited: 45
Showing 1-25 of 45 citing articles:
Molecular Mechanisms of Treatment Resistance in Glioblastoma
Alexander Ou, W.K. Alfred Yung, Nazanin Majd
International Journal of Molecular Sciences (2020) Vol. 22, Iss. 1, pp. 351-351
Open Access | Times Cited: 197
Alexander Ou, W.K. Alfred Yung, Nazanin Majd
International Journal of Molecular Sciences (2020) Vol. 22, Iss. 1, pp. 351-351
Open Access | Times Cited: 197
How CLSPN could demystify its prognostic value and potential molecular mechanism for hepatocellular carcinoma: A crosstalk study
Yanlong Shi, Yizhu Wang, Kaiyi Niu, et al.
Computers in Biology and Medicine (2024) Vol. 172, pp. 108260-108260
Closed Access | Times Cited: 16
Yanlong Shi, Yizhu Wang, Kaiyi Niu, et al.
Computers in Biology and Medicine (2024) Vol. 172, pp. 108260-108260
Closed Access | Times Cited: 16
Drug resistance mechanisms and treatment strategies mediated by Ubiquitin-Specific Proteases (USPs) in cancers: new directions and therapeutic options
Hongli Gao, Zhuo Xi, Jingwei Dai, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 16
Hongli Gao, Zhuo Xi, Jingwei Dai, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 16
The role of microRNA-338-3p in cancer: growth, invasion, chemoresistance, and mediators
Sepideh Mirzaei, Ali Zarrabi, Sholeh Etehad Asnaf, et al.
Life Sciences (2021) Vol. 268, pp. 119005-119005
Closed Access | Times Cited: 72
Sepideh Mirzaei, Ali Zarrabi, Sholeh Etehad Asnaf, et al.
Life Sciences (2021) Vol. 268, pp. 119005-119005
Closed Access | Times Cited: 72
Radiation-Triggered Selenium-Engineered Mesoporous Silica Nanocapsules for RNAi Therapy in Radiotherapy-Resistant Glioblastoma
Xianglong Tang, Zhen Wang, Yandong Xie, et al.
ACS Nano (2023) Vol. 17, Iss. 4, pp. 4062-4076
Closed Access | Times Cited: 32
Xianglong Tang, Zhen Wang, Yandong Xie, et al.
ACS Nano (2023) Vol. 17, Iss. 4, pp. 4062-4076
Closed Access | Times Cited: 32
Protein degradation: expanding the toolbox to restrain cancer drug resistance
Hui Ming, Bowen Li, Jingwen Jiang, et al.
Journal of Hematology & Oncology (2023) Vol. 16, Iss. 1
Open Access | Times Cited: 30
Hui Ming, Bowen Li, Jingwen Jiang, et al.
Journal of Hematology & Oncology (2023) Vol. 16, Iss. 1
Open Access | Times Cited: 30
USP3 promotes gastric cancer progression and metastasis by deubiquitination-dependent COL9A3/COL6A5 stabilisation
Xiaosheng Wu, Hao Wang, Danping Zhu, et al.
Cell Death and Disease (2021) Vol. 13, Iss. 1
Open Access | Times Cited: 41
Xiaosheng Wu, Hao Wang, Danping Zhu, et al.
Cell Death and Disease (2021) Vol. 13, Iss. 1
Open Access | Times Cited: 41
Deubiquitinase USP13 regulates glycolytic reprogramming and progression in osteosarcoma by stabilizing METTL3/m6A/ATG5 axis
Ce Wang, Yichen Meng, Jianquan Zhao, et al.
International Journal of Biological Sciences (2023) Vol. 19, Iss. 7, pp. 2289-2303
Open Access | Times Cited: 19
Ce Wang, Yichen Meng, Jianquan Zhao, et al.
International Journal of Biological Sciences (2023) Vol. 19, Iss. 7, pp. 2289-2303
Open Access | Times Cited: 19
Deubiquitinating enzymes: Promising targets for drug resistance
Fujing Ge, Yuekang Li, Tao Yuan, et al.
Drug Discovery Today (2022) Vol. 27, Iss. 9, pp. 2603-2613
Closed Access | Times Cited: 27
Fujing Ge, Yuekang Li, Tao Yuan, et al.
Drug Discovery Today (2022) Vol. 27, Iss. 9, pp. 2603-2613
Closed Access | Times Cited: 27
USP10 deubiquitinates RUNX1 and promotes proneural-to-mesenchymal transition in glioblastoma
Wenjin Qiu, Zumu Xiao, Yushi Yang, et al.
Cell Death and Disease (2023) Vol. 14, Iss. 3
Open Access | Times Cited: 16
Wenjin Qiu, Zumu Xiao, Yushi Yang, et al.
Cell Death and Disease (2023) Vol. 14, Iss. 3
Open Access | Times Cited: 16
Hexokinase 2 confers radio-resistance in hepatocellular carcinoma by promoting autophagy-dependent degradation of AIMP2
Yilin Zheng, Yizhi Zhan, Yuqin Zhang, et al.
Cell Death and Disease (2023) Vol. 14, Iss. 8
Open Access | Times Cited: 15
Yilin Zheng, Yizhi Zhan, Yuqin Zhang, et al.
Cell Death and Disease (2023) Vol. 14, Iss. 8
Open Access | Times Cited: 15
Hongyan Zhang, Wenjing Liu, Yingying Wu, et al.
Cancer Science (2024) Vol. 115, Iss. 7, pp. 2094-2106
Open Access | Times Cited: 5
Loss of deubiquitylase USP2 triggers development of glioblastoma via TGF-β signaling
Yiming Tu, Lei Xu, Jia Xu, et al.
Oncogene (2022) Vol. 41, Iss. 18, pp. 2597-2608
Closed Access | Times Cited: 21
Yiming Tu, Lei Xu, Jia Xu, et al.
Oncogene (2022) Vol. 41, Iss. 18, pp. 2597-2608
Closed Access | Times Cited: 21
USP3 promotes osteosarcoma progression via deubiquitinating EPHA2 and activating the PI3K/AKT signaling pathway
Anan Li, Shijiang Wang, Jiangbo Nie, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 3
Open Access | Times Cited: 4
Anan Li, Shijiang Wang, Jiangbo Nie, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 3
Open Access | Times Cited: 4
USP3 promotes DNA damage response and chemotherapy resistance through stabilizing and deubiquitinating SMARCA5 in prostate cancer
Sheng Li, Situ Xiong, Zhongqi Li, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 11
Open Access | Times Cited: 4
Sheng Li, Situ Xiong, Zhongqi Li, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 11
Open Access | Times Cited: 4
USP3 promotes clear cell renal cell carcinoma progression by stabilizing MYC and enhancing glycolysis
Zhiliang Xiao, Yuan Wang, Deng Pan, et al.
Biochimica et Biophysica Acta (BBA) - General Subjects (2025), pp. 130801-130801
Closed Access
Zhiliang Xiao, Yuan Wang, Deng Pan, et al.
Biochimica et Biophysica Acta (BBA) - General Subjects (2025), pp. 130801-130801
Closed Access
Lactylation-driven USP4-mediated ANXA2 stabilization and activation promotes maintenance and radioresistance of glioblastoma stem cells
Yiming Tu, Lei Xu, Guoqiang Fu, et al.
Cell Death and Differentiation (2025)
Open Access
Yiming Tu, Lei Xu, Guoqiang Fu, et al.
Cell Death and Differentiation (2025)
Open Access
UBTD2 protein molecules emerges as a key prognostic protein marker in glioma: Insights from integrated omics and machine learning analysis of GRM7, NCAPG, CEP55, and other biomarkers
Jia Lv, Shaoxun Li, Hongrui Zhang
International Journal of Biological Macromolecules (2025), pp. 143473-143473
Closed Access
Jia Lv, Shaoxun Li, Hongrui Zhang
International Journal of Biological Macromolecules (2025), pp. 143473-143473
Closed Access
Targeting the Ubiquitin System in Glioblastoma
Nico Scholz, Kathreena M. Kurian, Florian A. Siebzehnrübl, et al.
Frontiers in Oncology (2020) Vol. 10
Open Access | Times Cited: 31
Nico Scholz, Kathreena M. Kurian, Florian A. Siebzehnrübl, et al.
Frontiers in Oncology (2020) Vol. 10
Open Access | Times Cited: 31
ELF5 drives angiogenesis suppression though stabilizing WDTC1 in renal cell carcinoma
Tushuai Li, Longjiang Xu, Zhe Wei, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 10
Tushuai Li, Longjiang Xu, Zhe Wei, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 10
The Role of Smoothened-Dependent and -Independent Hedgehog Signaling Pathway in Tumorigenesis
Jian Yi Chai, Vaisnevee Sugumar, Mohammed Abdullah Alshawsh, et al.
Biomedicines (2021) Vol. 9, Iss. 9, pp. 1188-1188
Open Access | Times Cited: 22
Jian Yi Chai, Vaisnevee Sugumar, Mohammed Abdullah Alshawsh, et al.
Biomedicines (2021) Vol. 9, Iss. 9, pp. 1188-1188
Open Access | Times Cited: 22
Deubiquitinase USP18 regulates reactive astrogliosis by stabilizing SOX9
Wei Liu, Xuhui Ge, Zheng Zhou, et al.
Glia (2021) Vol. 69, Iss. 7, pp. 1782-1798
Closed Access | Times Cited: 20
Wei Liu, Xuhui Ge, Zheng Zhou, et al.
Glia (2021) Vol. 69, Iss. 7, pp. 1782-1798
Closed Access | Times Cited: 20
O-GlcNAcylation of melanophilin enhances radiation resistance in glioblastoma via suppressing TRIM21 mediated ubiquitination
Lei Xu, Yangfan Ye, Zeqiang Tao, et al.
Oncogene (2023) Vol. 43, Iss. 1, pp. 61-75
Closed Access | Times Cited: 7
Lei Xu, Yangfan Ye, Zeqiang Tao, et al.
Oncogene (2023) Vol. 43, Iss. 1, pp. 61-75
Closed Access | Times Cited: 7
The Emerging Role of Deubiquitinases in Radiosensitivity
Xiang Cao, Zhen Yan, Zihan Chen, et al.
International Journal of Radiation Oncology*Biology*Physics (2023) Vol. 118, Iss. 5, pp. 1347-1370
Open Access | Times Cited: 7
Xiang Cao, Zhen Yan, Zihan Chen, et al.
International Journal of Radiation Oncology*Biology*Physics (2023) Vol. 118, Iss. 5, pp. 1347-1370
Open Access | Times Cited: 7
Dysregulation of deubiquitination in breast cancer
Lili Kong, Xiaofeng Jin
Gene (2024) Vol. 902, pp. 148175-148175
Closed Access | Times Cited: 2
Lili Kong, Xiaofeng Jin
Gene (2024) Vol. 902, pp. 148175-148175
Closed Access | Times Cited: 2
